Bacterial ghosts as carrier and targeting systems for mucosal antigen delivery
- PMID: 12901596
- DOI: 10.1586/14760584.2.1.45
Bacterial ghosts as carrier and targeting systems for mucosal antigen delivery
Abstract
The application of new strategies to develop effective vaccines is essential in modern medicine. The bacterial ghost system is a novel vaccine delivery system endowed with intrinsic adjuvant properties. Bacterial ghosts are nonliving gram-negative bacterial cell envelopes devoid of cytoplasmic contents while maintaining their cellular morphology and native surface antigenic structures including bioadhesive properties. They are produced by PhiX174 protein E-mediated lysis of gram-negative bacteria. The intrinsic adjuvant properties of bacterial ghost preparations enhance immune responses against envelope-bound antigens, including T-cell activation and mucosal immunity. Since native and foreign antigens can be expressed in the envelope complex of ghosts before E-mediated lysis, multiple antigens of various origin can be presented to the immune system simultaneously. In addition, the extended bacterial ghost system represents a platform technology for specific targeting of DNA-encoded antigens to primary antigen-presenting cells. The potency, safety and relatively low production cost of bacterial ghosts offer a significant technical advantage, especially when used as combination vaccines.
Similar articles
-
Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors.Expert Rev Vaccines. 2004 Dec;3(6):681-91. doi: 10.1586/14760584.3.6.681. Expert Rev Vaccines. 2004. PMID: 15606353 Review.
-
Bacterial ghosts: non-living candidate vaccines.J Biotechnol. 1996 Jan 26;44(1-3):161-70. doi: 10.1016/0168-1656(95)00123-9. J Biotechnol. 1996. PMID: 8717400 Review.
-
Bacterial ghosts as adjuvant particles.Expert Rev Vaccines. 2007 Apr;6(2):241-53. doi: 10.1586/14760584.6.2.241. Expert Rev Vaccines. 2007. PMID: 17408373 Review.
-
Bacterial ghosts as multifunctional vaccine particles.Behring Inst Mitt. 1997 Feb;(98):191-6. Behring Inst Mitt. 1997. PMID: 9382740
-
Bacterial ghosts as antigen delivery vehicles.Adv Drug Deliv Rev. 2005 Jun 17;57(9):1381-91. doi: 10.1016/j.addr.2005.01.027. Epub 2005 Apr 20. Adv Drug Deliv Rev. 2005. PMID: 15878634 Review.
Cited by
-
Protective efficacy by various doses of Salmonella ghost vaccine candidate carrying enterotoxigenic Escherichia coli fimbrial antigen against neonatal piglet colibacillosis.Can J Vet Res. 2016 Jul;80(3):245-9. Can J Vet Res. 2016. PMID: 27408340 Free PMC article.
-
A novel inducible expression system for the functional study of toxic gene in bacteria.World J Microbiol Biotechnol. 2014 May;30(5):1527-31. doi: 10.1007/s11274-013-1573-0. Epub 2013 Dec 11. World J Microbiol Biotechnol. 2014. PMID: 24326910
-
A Review of Controlled Drug Delivery Systems Based on Cells and Cell Membranes.J Med Signals Sens. 2019 Aug 29;9(3):181-189. doi: 10.4103/jmss.JMSS_53_18. eCollection 2019 Jul-Sep. J Med Signals Sens. 2019. PMID: 31544058 Free PMC article. Review.
-
The Bacterial Ghost platform system: production and applications.Bioeng Bugs. 2010 Sep-Oct;1(5):326-36. doi: 10.4161/bbug.1.5.12540. Bioeng Bugs. 2010. PMID: 21326832 Free PMC article. Review.
-
Escherichia coli Nissle 1917 bacterial ghosts retain crucial surface properties and express chlamydial antigen: an imaging study of a delivery system for the ocular surface.Drug Des Devel Ther. 2015 Jul 21;9:3741-54. doi: 10.2147/DDDT.S84370. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26229437 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources